Suppr超能文献

常染色体显性多囊肾病无肾切除术的移植术

Transplantation in autosomal dominant polycystic kidney disease without nephrectomy.

作者信息

Knispel H H, Klän R, Offermann G, Miller K

机构信息

Department of Urology, Benjamin Franklin Medical Center, Free University Berlin, Germany.

出版信息

Urol Int. 1996;56(2):75-8. doi: 10.1159/000282815.

Abstract

Some transplantation centers still suggest nephrectomy in patients with autosomal dominant polycystic kidney disease (ADPKD) before kidney transplantation at least in selected cases. We wanted to learn whether prior nephrectomy is beneficial. The outcome of kidney transplantation in 47 consecutive ADPKD patients without prior nephrectomy was compared with that in matched controls with respect to complications of ADPKD. Although ADPKD patients were older than controls (mean, 50.1 vs. 40.3 years), there was no statistically significant difference in 1- and 5-year allograft survival between ADPKD patients and controls: 76.6 and 68.0%, respectively, in ADPKD patients, and 83.9 and 56.3% in controls. After a mean follow-up of 66.5 months 3 patients with ADPKD had cyst infections and were managed with antibiotics. Two patients had episodes of hematuria; neither required invasive therapy. There was no renal malignancy and clinical sign of urolithiasis in any patient. No posttransplantation nephrectomy was required. With only few indications remaining, there is no rationale for routine pretransplantation nephrectomy in patients with ADPKD.

摘要

一些移植中心仍然建议,对于常染色体显性多囊肾病(ADPKD)患者,至少在某些特定情况下,在肾移植前进行肾切除术。我们想了解预先进行肾切除术是否有益。将47例未预先进行肾切除术的连续性ADPKD患者的肾移植结果与匹配的对照组在ADPKD并发症方面进行比较。尽管ADPKD患者比对照组年龄更大(平均年龄分别为50.1岁和40.3岁),但ADPKD患者与对照组在1年和5年移植肾存活率方面无统计学显著差异:ADPKD患者分别为76.6%和68.0%,对照组分别为83.9%和56.3%。平均随访66.5个月后,3例ADPKD患者发生囊肿感染,经抗生素治疗。2例患者出现血尿;均无需侵入性治疗。所有患者均未发生肾恶性肿瘤及尿石症的临床症状。无需进行移植后肾切除术。由于仅剩下很少的适应证,对于ADPKD患者,没有理由进行常规的移植前肾切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验